Non-Small Cell Lung Cancer: 68GaNOTA-Anti-MMR Imaging Study

We are testing a new imaging agent to see how well it can identify certain immune cells in patients with non-small cell lung cancer. This may help improve imaging techniques for better diagnosis and treatment planning.

>2 years ≤5 visits Efficacy phase (II)No Placebo Cost Reimbursement Investigational Medicines InjectionOncologyOtolaryngologyPulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Estrogens Conjugated

Conjugated estrogens are hormones used to relieve menopausal symptoms like hot flashes and vaginal dryness.

Gallium (68ga) Chloride

Gallium-68 chloride is a radioactive tracer used in PET scans to help visualize tumors, infections, and other abnormal tissues.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

7-Triazacyclononane

Nanobody Against Macrophage Mannose Receptor

Triacetic Acid

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

UZ Brussel

Nuclear Medicine

Ganshoren, Belgium

Sponsor: UZ Brussel

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.